Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis
- PMID: 16844421
- DOI: 10.1016/j.cgh.2006.05.013
Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis
Abstract
Background & aims: Influence of being overweight and diabetes mellitus on the occurrence of hepatocellular carcinoma (HCC) in patients with cirrhosis has not been evaluated prospectively. The aim of this study was to show the predictive value of these factors in a cohort of 771 patients with well-compensated alcohol- or hepatitis C (HCV)-related cirrhosis who were screened prospectively for HCC.
Methods: The predictive value for HCC occurrence was assessed by using the log-rank test and the Cox proportional hazards model. At enrollment, the mean age was 61.4 +/- 10 years and 431 patients were men. Cirrhosis was caused by alcohol (n = 478), HCV (n = 220), or the association of both factors (n = 73). The mean body mass index (BMI) was 25.4 kg/m(2) and 231 patients were diabetic.
Results: During a mean follow-up period of 4.2 +/- 3 years, 220 patients developed HCC. In univariate analysis, a BMI of 25 kg/m(2) or more, diabetes, male sex, age older than 60 years, and HCV infection were risk factors for HCC. In multivariate analysis, predictive factors were a BMI between 25-30 kg/m(2) (hazard ratio [HR], 2.0; 95% confidence interval [CI], 1.4-2.7), BMI of 30 kg/m(2) or more (HR, 2.8; 95% CI, 2.0-4.0), diabetes (HR, 1.6; 95% CI, 1.2-2.1), age 60-70 years (HR, 2.4; 95% CI, 1.3-4.3), age older than 70 years (HR, 3.0; 95% CI, 1.7-5.5), male sex (HR, 2.0; 95% CI, 1.4-2.7), HCV (HR, 1.6; 95% CI, 1.1-2.2), and mixed (HR, 2.6; 95% CI, 1.7-4.0) etiology. We found a positive linear relationship between BMI level and HCC incidence during follow-up evaluation.
Conclusions: Overweight and diabetes mellitus are associated with an increased risk of HCC occurrence in patients with HCV- or alcohol-related cirrhosis.
Similar articles
-
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.Cancer. 1999 May 15;85(10):2132-7. Cancer. 1999. PMID: 10326690
-
Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.Alcohol Clin Exp Res. 2003 Aug;27(8 Suppl):47S-51S. doi: 10.1097/01.ALC.0000079449.47468.B0. Alcohol Clin Exp Res. 2003. PMID: 12960507
-
The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses.Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2054-60. doi: 10.1158/1055-9965.EPI-08-1131. Epub 2009 Jun 23. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19549812
-
Hepatocellular carcinoma and hepatitis C in the United States.Hepatology. 2002 Nov;36(5 Suppl 1):S74-83. doi: 10.1053/jhep.2002.36807. Hepatology. 2002. PMID: 12407579 Review.
-
Etiological factor of hepatocellular carcinoma in Italy.Minerva Gastroenterol Dietol. 2005 Mar;51(1):1-5. Minerva Gastroenterol Dietol. 2005. PMID: 15756142 Review.
Cited by
-
Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients.Hepatol Int. 2024 Oct;18(Suppl 2):922-940. doi: 10.1007/s12072-024-10692-4. Epub 2024 Jul 16. Hepatol Int. 2024. PMID: 39012579 Review.
-
The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis.Cancers (Basel). 2024 Apr 15;16(8):1505. doi: 10.3390/cancers16081505. Cancers (Basel). 2024. PMID: 38672587 Free PMC article. Review.
-
Role of body mass index and weight change in the risk of cancer: A systematic review and meta-analysis of 66 cohort studies.J Glob Health. 2024 Mar 29;14:04067. doi: 10.7189/jogh.14.04067. J Glob Health. 2024. PMID: 38547495 Free PMC article.
-
MAFLD: an optimal framework for understanding liver cancer phenotypes.J Gastroenterol. 2023 Oct;58(10):947-964. doi: 10.1007/s00535-023-02021-7. Epub 2023 Jul 20. J Gastroenterol. 2023. PMID: 37470858 Free PMC article. Review.
-
AAV induces hepatic necroptosis and carcinoma in diabetic and obese mice dependent on Pebp1 pathway.EMBO Mol Med. 2023 Jul 10;15(7):e17230. doi: 10.15252/emmm.202217230. Epub 2023 Jun 5. EMBO Mol Med. 2023. PMID: 37272212 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
